Most Recent
J&J-owned Janssen Pharmaceutica has sued Juno Pharmaceuticals, alleging the Australian off-patent drug maker is threatening to infringe its patent for a schizophrenia drug by seeking to list its own products on the PBS.
Mayne Pharma has won a dispute with US drug maker Cosette over the termination of a $672 million merger agreement, with a judge finding Mayne did not breach its continuous disclosure obligations by failing to disclose a letter from the US FDA sooner.
Construction PRO
Mutual company Australian Unity has sold the Greensborough Medical Centre and Day Hospital in Victoria to the Property Advisory for $32.5 million.
The Victorian Supreme Court has granted cosmetic surgeon Daniel Lanzer an extension to provide discovery in a class action against him and his clinic after hearing he was facing medical issues.
Blooms the Chemist can't overturn a decision from the Pharmacy Council of NSW blocking the registration of a chemist, with a judge finding there was no evidence Blooms would not have a financial interest in the business.
ASX-listed biotech 4D Medical has sued competitor Cyclopharm alleging the company made false, misleading and malicious statements about its rival during an online webinar prompted by a "fake" question.
Samsung Bioepis has successfully opposed Janssen's bid to patent a monoclonal antibody to treat ulcerative colitis, but an IP Australia delegate has given the J&J-owned company a chance to fix its application.
In the first-ever civil penalty proceedings for breaches of the Privacy Act, pathology services provider Australian Clinical Labs has been ordered to pay $5.8 million over a 2022 data breach that compromised the sensitive personal information of 223,000 customers of its Medlab business.
Pharmaceutical giant Johnson & Johnson has denied knowingly selling alleged ineffective medications under its Benadryl, Sudafed and Codral brands, saying research indicated the phenylephrine-containing products worked.
The federal government has hit back against a class action by single women and same-sex couples deemed “socially infertile” and denied Medicare rebates for IVF, denying group members were treated less favourably because of their marital status or sexual orientation.